|
|
楼主 |
发表于 2025-5-3 20:37:44
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑 " s7 s: x) T& P6 v
+ Q- X% ]$ a' D- k" \" x
今年ASCO大会，肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU，腹部肿瘤和生物治疗科今年哑火了 s$ j( J. J" |9 t; g# ^3 i3 P9 x
1 b" Y& ` v9 _; A
头颈肿瘤BU入选ASCO 2025的研究6 `' Y; K( p2 l2 b8 t x/ [
Hot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.) Z$ y1 d* |& V8 y0 H$ T
肿瘤内科-头颈肿瘤科姜愚团队
8 C: Z* K3 ^ }: ]4 I% s0 m3 Z$ c }
Neoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial. r% p3 F+ y, C* m2 c3 k7 `9 R2 w! x' H
肿瘤内科-头颈肿瘤科刘磊团队
- R$ I6 _8 @7 H$ r! b s7 `- D1 K& {$ u0 N& k
A phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy.
" x, F+ S2 B& N肿瘤内科-头颈肿瘤科刘磊团队4 J/ i( p: x( j
& _ n/ u0 @; c/ ~A phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy.
8 T; p+ c1 V6 I3 t6 D k肿瘤内科-头颈肿瘤科刘磊团队
, P- S! u% w B Q4 y) {; |$ |$ X+ x, a/ t$ ^3 @
ribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.
6 F3 c) k. J! s! [2 t' ]( c0 D* Q肿瘤内科-头颈肿瘤科姜愚团队
/ A% u: G2 }: i7 H8 X& g |
|
[复制链接]
发表于 2025-5-2 09:58:22
